Cullinan Associates Inc Medtronic PLC Transaction History

Cullinan Associates Inc

  • $1.81 Billion
  • Q3 2024

A detailed history of Cullinan Associates Inc transactions in Medtronic PLC stock. As of the latest transaction made, Cullinan Associates Inc holds 56,564 shares of MDT stock, worth $4.88 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
56,564
Previous 58,611 3.49%
Holding current value
$4.88 Million
Previous $4.61 Million 10.38%
% of portfolio
0.28%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$76.84 - $91.03 $157,291 - $186,338
-2,047 Reduced 3.49%
56,564 $5.09 Million
Q2 2024

Jul 10, 2024
SELL
$78.71 - $87.02 $723,895 - $800,322
-9,197 Reduced 13.56%
58,611 $4.61 Million
Q1 2024

Apr 18, 2024
SELL
$82.84 - $88.09 $864,849 - $919,659
-10,440 Reduced 13.34%
67,808 $5.91 Million
Q4 2023

Jan 24, 2024
SELL
$69.43 - $83.43 $3.4 Million - $4.08 Million
-48,917 Reduced 38.47%
78,248 $6.45 Million
Q3 2023

Oct 11, 2023
SELL
$78.22 - $90.4 $715,713 - $827,160
-9,150 Reduced 6.71%
127,165 $9.96 Million
Q2 2023

Jul 14, 2023
SELL
$79.47 - $91.38 $642,514 - $738,807
-8,085 Reduced 5.6%
136,315 $12 Million
Q1 2023

Apr 05, 2023
BUY
$76.72 - $87.58 $3.47 Million - $3.96 Million
45,256 Added 45.65%
144,400 $11.6 Million
Q4 2022

Jan 11, 2023
SELL
$76.18 - $87.74 $3.36 Million - $3.87 Million
-44,119 Reduced 30.8%
99,144 $7.71 Million
Q3 2022

Oct 19, 2022
BUY
$80.75 - $95.31 $315,651 - $372,566
3,909 Added 2.81%
143,263 $11.6 Million
Q2 2022

Jul 08, 2022
BUY
$87.4 - $113.09 $2.22 Million - $2.87 Million
25,402 Added 22.29%
139,354 $12.5 Million
Q1 2022

Apr 21, 2022
BUY
$100.58 - $112.38 $75,435 - $84,285
750 Added 0.66%
113,952 $12.6 Million
Q4 2021

Jan 07, 2022
BUY
$99.53 - $127.75 $118,042 - $151,511
1,186 Added 1.06%
113,202 $11.7 Million
Q3 2021

Oct 08, 2021
BUY
$122.75 - $135.17 $495,173 - $545,275
4,034 Added 3.74%
112,016 $14 Million
Q2 2021

Jul 07, 2021
BUY
$118.19 - $131.5 $1.94 Million - $2.16 Million
16,450 Added 17.97%
107,982 $13.4 Million
Q1 2021

Apr 20, 2021
SELL
$111.18 - $119.74 $17,232 - $18,559
-155 Reduced 0.17%
91,532 $10.8 Million
Q4 2020

Jan 14, 2021
BUY
$100.57 - $117.14 $146,329 - $170,438
1,455 Added 1.61%
91,687 $10.7 Million
Q3 2020

Oct 09, 2020
BUY
$90.13 - $108.78 $103,018 - $124,335
1,143 Added 1.28%
90,232 $9.38 Million
Q2 2020

Jul 07, 2020
BUY
$84.11 - $103.33 $46,260 - $56,831
550 Added 0.62%
89,089 $8.17 Million
Q1 2020

Apr 01, 2020
SELL
$72.92 - $121.3 $128,922 - $214,458
-1,768 Reduced 1.96%
88,539 $7.98 Million
Q4 2019

Jan 15, 2020
BUY
$104.49 - $114.54 $193,828 - $212,471
1,855 Added 2.1%
90,307 $10.2 Million
Q3 2019

Oct 01, 2019
SELL
$98.02 - $111.18 $400,803 - $454,615
-4,089 Reduced 4.42%
88,452 $9.61 Million
Q2 2019

Jul 16, 2019
BUY
$84.15 - $99.38 $67,740 - $80,000
805 Added 0.88%
92,541 $9.01 Million
Q1 2019

Apr 30, 2019
SELL
$82.45 - $93.79 $104,299 - $118,644
-1,265 Reduced 1.36%
91,736 $8.36 Million
Q4 2018

Jan 11, 2019
SELL
$85.8 - $99.49 $7,121 - $8,257
-83 Reduced 0.09%
93,001 $8.46 Million
Q3 2018

Oct 19, 2018
SELL
$85.91 - $99.17 $615,115 - $710,057
-7,160 Reduced 7.14%
93,084 $9.16 Million
Q2 2018

Jul 09, 2018
SELL
$77.48 - $87.83 $258,085 - $292,561
-3,331 Reduced 3.22%
100,244 $8.58 Million
Q1 2018

Apr 27, 2018
BUY
$76.55 - $87.26 $149,961 - $170,942
1,959 Added 1.93%
103,575 $8.31 Million
Q4 2017

Jan 17, 2018
SELL
$76.93 - $83.5 $151,552 - $164,495
-1,970 Reduced 1.9%
101,616 $8.21 Million
Q3 2017

Oct 16, 2017
BUY
$77.71 - $84.6 $8.05 Million - $8.76 Million
103,586
103,586 $8.06 Million

Others Institutions Holding MDT

# of Institutions
2,285
Shares Held
1.02B
Call Options Held
8.05M
Put Options Held
7.19M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email